New cancer drugs are making headlines, Iressa, Velcade, Avastin

New cancer drugs are making headlines, Iressa, Velcade, Avastin.

They each have an important new mechanism of action.

Iressa (gefitinib) is a new ORAL drug for lung cancer. It's an "epidermal growth factor inhibitor"...just for patients whose cancer progresses despite standard chemotherapy.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote